[New therapeutic possibilities. Future aspects].
Rubbert
A
A
Institut für Klinische Immunologie und Rheumatologie, Universität Erlangen-Nürnberg.
Burmester
G R
GR
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D001402:B-Lymphocytes / Q000276:immunology; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy / Q000379:methods*; D015166:Monitoring, Immunologic; D011994:Recombinant Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D016207:Cytokines; D011994:Recombinant Proteins; D016572:Cyclosporine